Results

Total Results: 931 records

Showing results for "estimating".

1. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/4y3P9DxovKMEjNmVd2mrPp
   December 01, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit Update on the Methods … Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit George F. … Because carotid artery stenosis screening has both known bene- fits and harms, estimating net benefit

2. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/benefit.pdf
   December 01, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit Update on the Methods … Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit George F. … Because carotid artery stenosis screening has both known bene- fits and harms, estimating net benefit

3. Procedure Manual Section 10. References | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-10-references
   July 10, 2017 - Preventive Services Task Force: estimating certainty and magnitude of net benefit.

4. Archived: Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
   December 15, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit Carotid Artery Stenosis … Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (PDF) … stenosis screening. 1-2 Because carotid artery stenosis screening has both known benefits and harms, estimating … Update on the Methods: estimating certainty and magnitude of net benefit.

5. Archived: Evidence Summary: False-Positive and False-Negative Rates of Digital Mammography Screening: Breast Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-false-positive-and-false-negative-rates-of-/breast-cancer-screening-january-2016
   January 11, 2016 - at the same radiology facility, we estimated robust SEs from logistic regression using generalized estimating … * 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating

6. Methods and Processes | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes
   June 01, 2019 - 03/2009 Update on Methods: Insufficient Evidence ( PDF File , 229 KB) 12/18/2007 Update on Methods: Estimating

7. Archived: Letter to the Editor and Response from the Evidence-Based Practice Center: Human Papillomavirus Testing to Screen for Cervical Cancer: Cervical Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
   February 15, 2012 - Estimating both effectiveness and overdiagnosis requires longitudinal data from at least two screening … calculated that 3.2 additional CIN2/CIN3 would be treated to prevent 1 case of incident cancer as a means of estimating

8. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
   May 01, 2018 - Re- estimating involved identifying values for each natural history component that allowed models to … Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence … MISCAN: estimating lead-time and over-detection by simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the magnitude of overdetection. … Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer

9. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
   www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
   May 01, 2018 - Re- estimating involved identifying values for each natural history component that allowed models to … Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence … MISCAN: estimating lead-time and over-detection by simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the magnitude of overdetection. … Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer

10. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
    May 01, 2018 - Models of overdiagnosis must attend carefully to the use of the appropriate data for estimating life … Estimating time of onset and clinical diagnosis requires context-specific information on incidence and … MISCAN: estimating lead-time and over-detection by simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the magnitude of overdetection. … Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence

11. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
    May 01, 2018 - Models of overdiagnosis must attend carefully to the use of the appropriate data for estimating life … Estimating time of onset and clinical diagnosis requires context-specific information on incidence and … MISCAN: estimating lead-time and over-detection by simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the magnitude of overdetection. … Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence

12. Final Research Plan: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-children-and-adolescents-screening
    June 30, 2022 - of pharmacotherapy): Large nonrandomized studies of interventions, defined as quantitative studies estimating

13. Individualizing Cancer Screening in Older Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/individualizing-cancer-screening-older-adults
    March 01, 2021 - Quality-adjusted life years estimated using preference-based measures are a prominent way for estimating … Lee S, Smith A, Widera E, et al. ePrognosis: Estimating Prognosis for Elders.

14. The U.S. Preventive Services Task Force: An Evidence-Based Prevention Resource for Nurse Practitioners | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/evidence-based-prevention-resource-nurse-practitioners
    April 01, 2019 - Preventive Services Task Force: Estimating certainty and magnitude of net benefit.  … Retrieved May 1, 2008, from  https://www.uspreventiveservicestaskforce.org/uspstf/update-methods-estimating-certainty-and-magnitude-net-benefit

15. Published Comment and Response: Comparing the USPSTF and GRADE Approaches to Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/published-comment-and-response-comparing-uspstf-and-grade-approaches-recommendations
    February 01, 2014 - Preventive Services Task Force: estimating certainty and magnitude of net benefit. 

16. Procedure Manual Section 6. Methods for Arriving at a Recommendation | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
    July 06, 2017 - Estimating the magnitude of benefit and harm of the preventive service. … Estimating the magnitude of the net benefit of the preventive service. … situations, the Task Force may also logically judge the lower bounds of the benefit, particularly when estimating

17. Screening for Ovarian Cancer: Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
    July 01, 1994 - The lifetime probability of developing ovarian can­ cer is 1 in 70. 3.3 In estimating potential benefits … in women with at least one ovary (compared with an unadjusted inci­ dence of 40 per 100 000). 3.4 Estimating … the test's perfor­ mance in screening asymptomatic women for ovarian can­ cer, is the ideal basis for estimating

18. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
    May 18, 2021 -   This analysis updated a 2016 modeling analysis estimating

19. Modeling Study: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/lung-cancer-screening
    March 09, 2021 - Objective: To inform the USPSTF guidelines by estimating the benefits and harms associated with various

20. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Accounting for these factors in estimating major gastrointestinal bleeding incidence may result in more